-
Federal Circuit Affirms Presumption of Separateness in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al., C.A. No. 24-2351 (Fed. Cir. Mar. 14, 2025)
11 Apr 2025 23:15 GMT
… in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al. and up …
-
Pfizer board approves marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacitane in India
21 Feb 2025 09:04 GMT
… Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited. The agreement focuses … Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited (“Mylan”) for Marketing …
-
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
19 Feb 2025 02:31 GMT
… Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir 2025) … Court.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025) … Taranto
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025 …
-
Latest Federal Court Cases: Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
05 Feb 2025 02:06 GMT
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Appeal Nos. 2024-1965, - …
-
Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch
12 Jan 2024 18:15 GMT
… Announcement
PITTSBURGH – Jan. 18, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is …
-
Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch
27 Oct 2023 15:09 GMT
… on some vials
Company Name:
Mylan Pharmaceuticals, Inc. a Viatris Company
Brand … - PITTSBURGH – April 12, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is …
-
National CSR drive deploys ‘Mobile Health ATMs’ to bring high-risk informal workers into India’s formal healthcare net via doorstep screening
05 Feb 2026 20:48 GMT
… in Gorakhpur in partnership with Mylan Pharmaceuticals—which is critical for India …
-
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)
14 Sep 2023 04:14 GMT
… Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc.
The case arose in … inter partes review initiated by Mylan Pharmaceuticals over Reissue Patent No. RE47 … ).
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)
Panel …
-
Genital Herpes Treatment Market Still Going Strong | Novartis, Mylan Pharmaceuticals, Teva Pharmaceuticals
31 Oct 2022 20:33 GMT
… , Vical, Maruho, Teva Pharmaceuticals Inc, Mylan Pharmaceuticals Inc., Apotheca Inc., Sandoz Inc … , Vical, Maruho, Teva Pharmaceuticals Inc, Mylan Pharmaceuticals Inc., Apotheca Inc., Sandoz Inc …
-
Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp. (Fed. Cir. 2022)
06 Oct 2022 04:44 GMT
… inter partes review (IPR) that Mylan Pharmaceuticals failed to show the claims … the asserted prior art, in Mylan Pharmaceuticals Inc. v. Merck Sharp … institution in the first place).
Mylan Pharmaceuticals Inc. v. Merck Sharp …
About
© 1995-2026